Advertisement

Topics

CarboGen and AMCIS Company Profile

12:32 EST 16th December 2018 | BioPortfolio

CarboGen and AMCIS, recognized as world leaders in the development chemistry market, combine world-class chemistry skills to provide seamless drug substance development and commercialization services. Dedicated to reducing the time, cost and risks associated with drug development, CarboGen and AMCIS focus on supporting the development process from bench to market. Together, we deliver integrated chemistry services that include:Early stage services, such as process research and rapid API supply, through CarboGen; and Late stage services such as process development and API manufacture for clinical trials and in-market supply, through AMCIS.

Location

Schachenallee 29
Aarau
CH-5001
Switzerland

Contact

Phone: (+41) 62-836 48 00
Fax: (+41) 62-836 48 10
Email: info@carbogen-amcis.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Carbogen Amcis opens new Japanese office

Carbogen Amcis (Swiss-based pharma process development and API manufacturing company) has opened a new office located in Kyoto, Japan.

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Preparation and evaluation of trityl-loaded lipid nanocapsules as oxygen sensors for Electron Paramagnetic Resonance oximetry.

Oxygen is essential in physiology and pathophysiology. Electron Paramagnetic Resonance (EPR) oximetry, using oxygen sensitive paramagnetic materials, could be attractive for measuring oxygen in tissue...

Clinical trials targeting hypoxia.

The concept of tumour hypoxia as a cause of radiation resistance has been prevalent for over 100 years. During this time, our understanding of tumour hypoxia has matured with the recognition that oxyg...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carbogen and niacinamide may make tumor cells more sensitive to radiation therapy. It is not yet k...

Randomized Trial of ARCON in Larynx Cancer

TITLE: A multicentre, randomised, phase III clinical trial comparing accelerated radiotherapy with accelerated radiotherapy plus carbogen and nicotinamide (ARCON) in clinical stage T2-4 ...

Companies [3 Associated Companies listed on BioPortfolio]

CarboGen and AMCIS

CarboGen and AMCIS, recognized as world leaders in the development chemistry market, combine world-class chemistry skills to provide seamless drug substance development and commercialization services....

CARBOGEN AMCIS AG

CARBOGEN AMCIS, recognized as world leader in the development chemistry market, provides world-class chemistry skills to provide seamless drug substance development and commercialization services. D...

CarboGen Laboratories

Faster-to-Market is the top priority of research-based pharmaceutical companies. CarboGen is a company that specializes in helping these companies accomplish this. For the last ten years CarboGen has ...

More Information about "CarboGen and AMCIS" on BioPortfolio

We have published hundreds of CarboGen and AMCIS news stories on BioPortfolio along with dozens of CarboGen and AMCIS Clinical Trials and PubMed Articles about CarboGen and AMCIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CarboGen and AMCIS Companies in our database. You can also find out about relevant CarboGen and AMCIS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record